Investment case
Health Catalyst, Inc.
HCAT · 3 developments mapped · last assessed 2026-09-15
Market Ontology has mapped 3 macro, policy, and market developments to Health Catalyst, Inc. since 2026-09-15. Each one is traced from the driver to the valuation assumption it moves, and the valuation below is run on the same engine the subscription uses.
Valuation
No validated run has been published for HCAT yet, so no modelled value is shown. The HCAT valuation is in the public catch-up queue.
Subscribers do not wait for the weekly cycle: they run HCAT on demand, against live prices and the latest filings, and change any assumption the developments below move.
Filed financials
Current case
- Open question
Health Catalyst Appoints Simeon Kohl as CEO with 2.75M RSU Inducement Grant
Leadership change, potential strategic shift, and share dilution from RSU grant.
· Moves future growth rate, management effectiveness, cost structure efficiency
What changed, by assumption
- 2026-09-15Health Catalyst Appoints Simeon Kohl as CEO with 2.75M RSU Inducement Grant
- 2026-09-15Health Catalyst appoints Simeon Kohl as CEO with 2.75M share inducement award
- 2026-09-15Health Catalyst Appoints Simeon Kohl CEO With 2.75M Inducement Share Grant
Event impact log
Full ledger →| Date | Mechanism | Direction | Horizon | Impact |
|---|---|---|---|---|
| 2026-09-15 | Health Catalyst Appoints Simeon Kohl as CEO with 2.75M RSU Inducement Grant | mixed | 1-3m | 0.60 |
| 2026-09-15 | Health Catalyst appoints Simeon Kohl as CEO with 2.75M share inducement award | mixed | 1-3m | 0.60 |
| 2026-09-15 | Health Catalyst Appoints Simeon Kohl CEO With 2.75M Inducement Share Grant | mixed | 1-3m | 0.60 |